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Experimental glomerulonephritis induced by in situ
formation of immune complexes in glomerular capillary wall
STEVEN M. GOLBUS and CURTIS B. WILsoN
Department of Immunopathology, Research Institute of Scripps Clinic, La Jolla, California
Experimental glomerulonephritis induced by in situ formation of
immune complexes in glomerular capillary wall. An experimental
model of glomerulonephritis was produced by the in situ forma-
tion of immune complexes directly in the glomerular capillary
wall. Perfusing the lectin concanavalin A (Con A) into the left
renal arteries of rats led to its binding diffusely to the glycopro-
teins of the glomerular capillary wall of only that kidney in each
animal. The subsequent reaction with anti-Con A antibody (ei-
ther administered systemically or actively induced) resulted in
an exudative and proliferative glomerulonephritis confined to the
Con A perfused kidney. Immunofluorescence disclosed the dif-
fuse deposition of immunoglobulin, Con A, and C3 in the per-
fused, but not the unperfused kidney. The quantitative rela-
tionship between antigen and antibody binding and histologic
outcome was determined. Since lectins have been found in
mammalian tissues, as well as in infectious agents that are patho-
genic in man, a series of events conceptually similar to this in situ
model may occur in some cases of glomerulonephritis in man.
Glomérulonéphrite experimentale déterminêe par Ia formation in
situ de complexes immuns dans Ia paroi du capillaire glomerulaire.
Un modèle experimental de glomerulonephrite a été produit par
Ia formation in situ de complexes immuns dans la paroi du capil-
laire glomérulaire. La perfusion de concavaline A (Con A) dans
les artères rdnales gauches de rats entraIne Ia liaison diffuse du
produit aux glycoprotéines de Ia paroi du capillaire glomerulaire
seulement dans Ic rein injecté. Les reactions ultérieures avec un
anticorps anti-Con A (soit administrd par voie systémique, soit
induit activement) ont pour consequence une glomerulonephrite
exsudative et proliferative localisée au seul rein injecté.
L'immunofiuorescence montre des dépôts diffus dimmunoglob-
uline, de Con A, et de C3 dans Ic rein perfuse mais non dans
le rein oppose. Les relations quantitatives entre Ia liaison et
l'évolution histologique ont dté déterminées. Du fait que des
lectines ont été trouvées aussi bien dans les tissus des mam-
mifères que dans des agents infectieux pathogènes pour
l'homme, il est possible qu'une sequence d'évênements con-
ceptuellement similaire a ce modCle in situ puisse survenir dans
certains cas de glomérulonephrite chez l'homme.
Experimental and clinical investigations have de-
lineated two major initiating mechanisms of immu-
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nopathologically mediated glomerulonephritis [1].
The first occurs when either an exogenous or an en-
dogenous antigen combines with serum antibodies
to form circulating immune complexes, which sub-
sequently deposit in the glomerulus. The other
mechanism entails the reaction of specific antibody
with antigens already present in the glomerulus.
The antigen-antibody reaction in this case occurs
locally, directly at the site of tissue injury. Classi-
cally, the antigen in this second mechanism is the
glomerular basement membrane, a major structural
component of the glomerulus. Glomerular antigens
other than those of the basement membrane can be
involved similarly, although to date examples have
been identified only in experimental models [2, 3].
A logical extension of this in situ immunologic
mechanism could involve a foreign, nonglomerular
material in the role of the antigen if it was first
trapped in or bound to the glomerulus. We tested
this hypothesis by using the lectin concanavalin A
(Con A) isolated from the jack bean Canavalia ensi-
formis, since it is immunogenic and can bind to the
mannose and glucose [4] present in the structural
glycoproteins [5] of the glomerular capillary wall
[6].
Methods
Animals. Male Brown Norway rats, each weigh-
ing 200 to 250 g, were used for all but one experi-
ment. The endogenous antibody and its control
were done in male Lewis rats.
Surgical procedure. Rats were anesthetized, and
the left renal artery of each was cannulated with a
30-gauge hook needle after dilatation with topical
papaverine. Con A was perfused into the left kidney
at a rate of 0.25 mI/mm (usually a volume of 1 ml),
after which the tubing was flushed with an addition-
al 0.5 ml of sterile saline. Fifteen minutes after per-
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fusion, the rats were injected systemically with the
y globulin fraction of either rabbit anti-Con A anti-
serum or normal rabbit serum (NRS), or they re-
mained uninjected. The initial 4 ml was given intra-
venously, and any that remained was administered
subcutaneously.
Experimental protocols. Group Ia: Renal binding
of Con A. The effect of dose on binding was eval-
uated in subgroups of six rats each, perfused with
500, 350, 200 or 50 g of 1251-Con A and sacrificed 15
mm later. Group ib: Effect of a-methyl-mannoside.
To investigate the competitive removal of Con A
from the glomerulus by its natural sugar ligand a-
methyl-mannoside, we perfused rats with 350 g of
12I-Con A, followed in 5 mm by 1 ml of 1 M a-
methyl-mannoside. The rats were sacrificed 10 mm
later.
Group 2: Nephritogenic effect of Con A perfusion
followed by systemic anti-Con A antiserum. Rats
perfused with 500 zg of Con A were injected 15 mm
later with 245.0, 171.5, 98.0, or 24.5 mg (protein) of
anti-Con A antiserum. Subgroups were sacrificed
after 1 or 5 days. In a subgroup of these rats, the
right kidneys were removed just before routine left
renal perfusions of 500 g of Con A; 245 mg of anti-
Con A antiserum was administered, and the rats
were sacrificed 5 days later.
Group 3: Effect of delaying the anti-Con A anti-
serum injection. Rats were perfused with 500 g of
Con A, as above. Three days later they were inject-
ed with 245 mg of anti-Con A antiserum, and 5 days
after the injection of antiserum, they were sacri-
ficed.
Group 4. Nephritogenic effect of Con A perfusion
in rats producing endogenous anti-Con A antibody.
Lewis rats were immunized with 500 of Con A in
incomplete Freund's adjuvant at monthly intervals.
The development of anti-Con A antibodies was as-
sessed by indirect immunofluorescence, with a Con
A perfused rabbit kidney as a target. The rats were
used when their antibody titer was  1:160. Each
animal's left renal artery was occluded and its kid-
ney flushed free of blood with I cc of sterile saline.
The kidney was then perfused with 500 p.g of Con A
in the usual manner. The rats were sacrificed 5 days
later.
Controls. In addition to the control unperfused
right kidney of each experimental animal, we used
the following sets of controls.
Group 5: Con A perfusion followed by systemic
normal rat serum (NRS). Rats were perfused with
500 ig of Con A and then injected with 245 mg of
NRS. Subgroups were sacrificed at 1 and 5 days.
Group 6.' Sterile saline perfusion followed by sys-
temic anti-Con A antiserum. Rats were perfused
with 1 ml of 0.15 M sterile saline and then injected
with 245 mg of anti-Con A antiserum. Subgroups
were sacrificed at 1 and 5 days.
Group 7. Con A perfusion followed by delayed in-jection of NRS. Rats were perfused with 500 g
Con A, and 3 days later were injected with 245 mg
of NRS. They were sacrificed 5 days after the NRS
injection.
Group 8: Con A perfusion in sham-immunized
rats. Lewis rats were injected repeatedly with in-
complete Freund's adjuvant (without Con A).
These rats then underwent the same surgical and
postsurgical protocol as group 4.
All groups consisted of at least three or four rats
per group of subgroup. Immunofluorescence of
both kidneys, as well as histology of liver, spleen,
heart, lung, and left and right kidneys was done on
all rats. Specific renal uptake of Con A and/or anti-
Con A antibody was determined in groups Ia, lb, 2,
5, and 6 by using radiolabeled Con A or anti-Con A
antiserum. Electron microscopy was performed on
selected animals in group 2. Animals in groups 2, 4,
5, 6, and 8 had daily 24-hr urinary protein excretion
measured, and serum creatinine concentrations
were determined preoperatively and at sacrifice.
Reagents. Con A (Lot 144), three times crystal-
lized, was purchased from the Miles Yeda Corpora-
tion, Elkhart, Indiana. For injection, the Con A was
dissolved in sterile 0.15 M saline (pH, 6.8) and
cleared at 6000 rpm in a Sorvall RC2-B centrifuge.
The Con A protein content was calculated on the
basis of a 15.2% nitrogen content [7] or estimated
spectrophotometrically at 280 nm, using an ex-
tinction coefficient (Em) of 12.8 calculated from
our nitrogen determinations. Crystalline bovine
serum albumin (BSA) was from Reheis Chemical
Corporation, Chicago, Illinois. Alpha-methyl-man-
noside, grade II, was from the Sigma Chemical Cor-
poration, St. Louis, Missouri.
Antisera. Rabbit anti-Con A antiserum was pre-
pared by immunizing rabbits at monthly intervals
with 3 mg of Con A in incomplete Freund's adju-
vant. For injection, a y-globulin fraction of the anti-
Con A antiserum (or NRS) was produced by precip-
itation with ammonium sulfate at a final concentra-
tion of 50%. All anti-Con A antiserum used was
from a single pool with a protein concentration of
24.5 mg/mi and an antigen binding capacity (ABC-
33, at 1 g of Con AIml) of 890 pg Con AIml of
antisera. The micrograms of anti-Con A antibody in
the anti-Con A antiserum was not determined but
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was probably less than 1% of the total protein based
on the amount bound in the kidney (see Results).
Antiserum to rat C3 prepared by the method of
Mardiney and MUller-Eberhard [8] showed only a
single line on immunoelectrophoresis with fresh
whole rat serum, but was additionally absorbed
with rat IgG.
Radiojodination. Proteins were labeled with 125J
or 131J by the chloramine-T method of McConahey
and Dixon [9].
Histology. The tissues were fixed in Bouin's solu-
tion and embedded in paraffin; 4- sections were
then stained with hematoxylin and eosin (H&E) or
periodic acid Schiff (PAS).
linmunofluorescence. Tissue to be examined by
immunofluorescence was snap-frozen in liquid ni-
trogen. Frozen sections were stained with fluores-
cein isothiocyanate (FITC)-conjugated antibodies
[10] specific for rabbit IgG, rat IgG, rat C3, and Con
A as previously described [11]. The FITC-con-
jugated rabbit anti-Con A and goat antirabbit IgG
antisera were absorbed with normal rat serum be-
fore use. Lesions seen by direct fluorescence were
graded semiquantitatively from 0 to 4+. In kidneys
in which not all glomeruli were positive, "focal"
means some, but not all, glomeruli, and "segmen-
tal" means part, but not all, of a glomerulus.
Electron microscopy. Tissues to be examined by
electron microscopy were diced and fixed in chilled
2% glutaraldehyde in 0.1 M cacodylate buffer (pH,
7.4) and then postfixed for 1 hr in 1% buffered osmic
acid. They were then dehydrated through a series of
alcohols, washed clear with propylene oxide, and
embedded in Epon 812 (Ladd Research Industries,
Inc., Burlington, Vermont). The sections (500 to
700 A) were stained with uranyl acetate and lead
citrate and were examined at 5000 to 17,000 magni-
fications with a Hitachi hA electron microscope
(Perkin-Elmer Corporation, Hitachi-Perkin-Elmer
Instruments, Mountain View, California). Portions
of two glomeruli from each rat studied were exam-
ined.
Laboratory determinations. We evaluated 24-hr
urine samples for protein content by the sulfosali-
cylic acid method [12]. Excretion of greater than 15
mg/24 hr was considered abnormal. Serum creati-
nine was measured with a kit from Hycel, Inc.,
(Houston, Texas). Values above 1.2 mg/dl were
considered abnormal.
Specific uptake and binding of radiolabeled pro-
teins with the paired label technique. For paired la-
bel injections, an equal amount of 1311-BSA was in-
jected when 1251-Con A was injected; trace amounts
f 131INRs were injected along with the '231-anti-
Con A. Injected animals' kidneys were removed at
sacrifice and frozen at —20° C until use. For deter-
mining specific radioactivity, the kidneys were ho-
mogenized in a Waring Blendor; the homogenate
was washed three times in PBS and then counted in
a well-type gamma scintillation counter. Correction
for counts contributed by nonspecifically trapped
serum was made by the formula [13]:
Specific renal uptake of 125J = renal 125J —
serum 131![
serum 123J x organ 131J
and the jig of protein/gm of kidney was calculated
from the specific activity.
Results
Group 1, a and b: Renal binding of Con A. The
quantities of Con A specifically bound to rat kid-
neys 15 mm after perfusion (shown in Table 1) in-
creased as the dose increased. Perfusion of 500 jig
of Con A, the dosage chosen for inducing disease,
resulted in a binding of 74.7 jig Con A/g of the per-
fused kidney, which was 100-fold greater than the
amount bound to the nonperfused kidney. In group
ib, Con A perfusion was followed by perfusion with
a-methyl-mannoside (the natural sugar ligand of
Con A), resulting in competitive removal of 80% of
the lectin bound to the left kidney.
By immunofluorescence, the Con A perfused kid-
ney contained irregular yet virtually continuous de-
posits of Con A along the capillary walls of most
glomeruli (Fig. 1A). In some areas, the deposits had
a segmental, nearly confluent, granular appearance,
but a few glomeruli had no detectable deposits. In
addition, the peritubular capillaries contained weak
focal staining. The distribution and intensity of gb-
merular and peritubular capillary Con A deposits
correlated with the dose of Con A infused; that is,
diffuse and 4+ in groups given the highest doses and
essentially negative in half of the group given the
lowest dose. Rats in which Con A binding was
competitively reduced with a-methyl-mannoside
showed much less Con A staining than those given
the same dose of Con A alone (3+ vs. 0 to 1+). No
rats had visible glomerular C3 deposits, indicating
that the binding of Con A to glomeruhi did not in-
duce the fixation of this central component of the
complement cascade. No Con A deposits were de-
tected in the nonperfused kidneys. Both kidneys
were histologically normal in all rats.
Group 2: Nephritogenic effect of Con A perfusion
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Table 1. Amount of '251-Con A bound to perfused renal tissue (groups Ia and b)
1251-Con A boundb
Experimental conditions
1251-Con A infusedg
gIg ofkidney
Left kidney Right kidney
Group la, dose response 300
350
200
50
74.7 18.6 0.7 0.1
48.9 9.1 0.7 0.1
23.1 6.2 0.4 0.1
13.8 5.0 0.1 0.02
Group 1b,350/Lg'2I-ConAfollowedbyo-methyl-mannoside 9.6 0.9 1.2 0.1
a Rats were sacrificed 15 mm after 1251-Con A was perfused into left renal artery.
b Values are means SEM.
followed by systemic anti-Con A antiserum. The
amounts of 1251-anti-Con A antibody fixing to rat
kidneys previously perfused with 500 tg of Con A
are shown in Table 2. One day after the injection of
from 24.5 to 245 mg of antiserum, 4.1 to 122.7 j.g of
anti-Con A antibody was protein bound per gram of
kidney. After 5 days, 0.6 to 51.6 g antibody/g of
kidney remained bound. As expected from the
amounts of Con A found in the nonperfused side,
only minute amounts of antibody bound in the non-
perfused kidney. Control rats perfused with sterile
saline followed by the systemic injection of 245 mg
of 1251-anti-Con A antiserum had no quantifiable
anti-Con A antibody bound in either kidney at I or 5
days.
The effect of time and the presence of anti-Con A
antibody on the disappearance of glomerular-bound
1251-Con A were determined quantitatively to inter-
relate the two reactants. When anti-Con A anti-
serum was injected following the perfusion of 500
g of 1251-Con A, 21.1 and 7.9 sg of Con A remained
bound per gram of perfused kidney after 1 and 5
days, respectively. In comparison, only 6.5 and
1.1 g of Con A, respectively, remained bound per
gram of kidney when the same amount of NRS was
injected. Thus, when anti-Con A antibody reacts
with the glomerular-bound Con A, the retention of
Con A in the glomerular capillary wall is enhanced.
Rats given Con A followed by 98 to 245 mg of
anti-Con A antiserum evolved a pattern and distri-
bution of glomerular deposits of Con A and rabbit
IgG similar to the Con A found in group 1 rats:
widespread, segmentally variable, 2 to 4+ irregular
yet virtually continuous fluorescent deposits along
most glomerular capillary walls (Fig. 1B, C, and D).
In some areas, the deposits appeared to be in a seg-
mental granular or nearly confluent fine granular
pattern. Deposits of C3 were distributed similarly,
although they were generally more granular in ap-
pearance. Small amounts of rabbit IgG and Con A,
without detectable C3, were in scattered peritubular
capillaries. The only difference noted between the
first and fifth days was that rat IgG was present in a
faint segmental deposition along some glomerular
capillary walls in 3 of 13 rats, presumably reflecting
the formation of host antibodies to rabbit IgG or
Con A. Rats that received only 24.5 mg of anti-
serum had only 1 + fine, segmental deposits of rab-
bit IgG and Con A, without C3, at 1 day. At 5 days,
these rats had 0 to 1 + granular deposits of rabbit
IgG, trace 3+ coarse granular deposits of Con A,
but no detectable rat IgG or C3. None of the rats,
regardless of the dose of antibody they received,
had any significant detectable deposition of Con A,
C3, or IgG in their untreated kidneys.
Lungs, hearts, livers, and spleens of three rats
were examined by immunofluorescence I day after
they received Con A followed by 245 mg of anti-
Con A antiserum and sacrifice. There was no dis-
cernible difference in staining of these four organs
between rats that received antibody and rats that
received an equivalent amount of NRS after the
standard Con A perfusion.
Histologic examination of rats given Con A fol-
lowed by 97 to 245 mg of anti-Con A antiserum and
sacrificed 24 hr later revealed that 9 of 11 had gb-
merulonephritis in the perfused kidneys (Fig. 2A).
In addition to early proliferative changes, there was
a marked influx of polymorphonuclear leukocytes
(PMNs) into the glomeruli, with up to 30 PMNs
present per glomerulus. In some areas, the lesions
were segmental, or focal or both. The untreated kid-
neys of all rats were normal. In addition, rats given
only 24.5 mg of antibody had no histologic changes.
Electron microscopic examination of involved
kidneys from animals sacrificed after I day revealed
that at some points the endothelium was stripped
off the gbomerular basement membrane, and PMNs
were in direct contact with the basement membrane
(Fig. 3). In addition, fuzzy densities were present
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Fig. 1. (A) Nearly continuous deposition of Con A along the glomerular capillary wall of a rat kidney removed 15 mm after renal artery
infusion of Con A (group Ia) (original magnification, x400). Essentially continuous deposits (similar to A) of both Con A (B) and rabbit
IgG (C and D) along the glomerular capillary wall. Perfused kidney from a rat was given Con A intrarenally, then was injected system-
ically with rabbit anti-Con A antiserum and sacrificed 24 hr later (group 2) (original magnification of B and C, x400; of D, x650). (E and F)
Relatively granular appearance of rat IgG deposits along the glomerular capillary wall. Con A perfused kidney was from a rat making
endogenous anti-Con A antibodies (group 4) (original magnification of E, x400; of F, x650.)
(4
5'
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Table 2. Amount of '251-anti-Con A antibody fixed to renal-bound Con A (group 2)
'251-anti-Con A
antiserum
injected
mg
125l-anti-Con A antibody fixedb
g/g of left (perfused) kidney
Histologic glomerulonephritis
No. with lesions
(Severity C)No. exp. animals
Atiday At5days Atiday At5days
245.0 122.7 18.6 51.6 19.2 3/5(3+) 6/7(4+)
171.5 90.0 10.2 40.7 2.4 3/3(3+) 3/3 (4+)
98.0 72.4 21.9 41.7 7.0 3/3(3+) 2/3 (2+)
24.5 4.1 0.8 0.6 0.1 0/3 (0) 0/3 (0)
a Right nonperfused kidney ranged from 0.1 to 3.7 /J.glg.
Values are means SEM.
Arbitrary scale of 0 (no lesion) to 4+ is used.
Fig. 2. (A) Marked influx of PMNs (arrow) as well as an early increase of endocapillary cells
in the perfused kidney from a rat given Con A intrarenally, then injected systemically with
rabbit anti-Con A antiserum and sacrificed 24 hr later (PAS; original magnification, X 250).
(B) Markedly distorted glomerular architecture, increased endocapillary cells and
occlusion of capillary lumens in the perfused kidney from a rat given Con A intrarenally,
then injected systemically with 245 mg of rabbit anti-Con A antiserum and sacrificed after 5
days (PAS; original magnification, x250). (C) Glornerulus showing mild glomerulonephritis
(compare to B) in the perfused kidney from a rat given Con A intrarenally, the injected
systemically with 98mg of rabbit anti-Con A antiserum and sacrificed after 5 days (PAS;
original magnification, x250). (D) Marked PMN infiltration (arrow) as well as severe
proliferative glomerulonephritis in the perfused kidney from a rat making endogenous anti-
Con A antibody and sacrificed 5 days after intrarenal infusion of Con A (PAS; original
magnification, x 250.)
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Fig. 3 Electron micrograph of a glomerulus from the perfused kidney of a rat given Con A
intrarenally, then injected systemically with rabbit anti-Con A antiserum and sacrificed after
24 hr. The endothelium is stripped off the glomeriilar basement membrane (large arrows). A
PMN is in direct contact with the basement membrane. Fuzzy densities (small arrow) are
present along the subendothelial aspect of the glomerular basement membrane
(magnification, x 13,037).
on the subendothelial aspect of the glomerular base-
ment membrane, and probably represent Con A-
anti-Con A antibody complexes. Immunoperoxi-
dase studies are currently in progress to explore fur-
ther the composition of these densities.
The severity of the lesion at 5 days correlated
well with the amount of antibody injected and the
quantity of antibody bound at 24 hr (Table 2). The
gross and histologic lesions in the perfused kidneys
in nine of ten rats that received Con A followed by
171 or 245 mg of antiserum were the most marked.
Grossly, these kidneys were enlarged and their sur-
faces were often granular and studded with pe-
techiae. Microscopically, the glomeruli were swol-
len and their architecture was distorted (Fig. 2B).
The glomerular PMN infiltration was still present,
although milder. The disease was now character-
ized by a marked increase in endocapillary cells
with the obliteration of many of the capillary lu-
mens. About one third of the rats had early crescent
formation in some glomeruli. Many glomeruli had
eosinophilic material in Bowman's space. There
were scattered foci of interstitial mononuclear cell
infiltrates, and casts in the tubules were wide-
spread. Two of the three rats that received 97 mg of
anti-Con A antiserum had mild proliferative lesions,
with patent capillary lumens, no significant PMN in-
flux, and no glomerular crescents (Fig. 2C). The
third rat, which did not have histologic changes,
had the least 1251-anti-Con A antibody bound. Ani-
mals that received only 24.5 mg of anti-Con A anti-
serum had no histologic changes. The right kidneys,
lungs, spleens, livers, and hearts of all rats in group
2 were no different from those of controls at both 1
and 5 days.
Despite the considerable histologic damage, the
discernible effect on glomerular function was slight.
None of the experimental animals was proteinuric
in the first 24 hr. Nine out of sixteen rats sacrificed
on day 5 after Con A and a nephritogenic dose of
anti-Con A antiserum had been proteinuric for at
least 1 day, all within the range of 16 to 51 mg/day.
a-—., •--
!t.• C:!.
r.
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Only one of sixteen rats had an elevated serum
creatinine.
Because the normal right kidney of the rats in
group 2 might have been preventing a detectable
rise in serum creatinine or urinary protein excre-
tion, we removed the right kidneys of four rats just
before perfusing them with Con A and then inject-
ing 245 mg of antiserum. After the first 24 hr, all
four rats became persistently proteinuric. Their
serum creatinine rose from a preoperative mean of
0.65 to 1.5 mg/dl at sacrifice on day 5. All had histo-
logic evidence of glomerulonephritis in their left
kidneys.
Group 3: Effect of delaying the anti-Con A anti-
serum injection. Preliminary studies had shown that
by 1 to 2 days after perfusing a kidney with Con A,
the Con A was distributed in that kidney as ito 3+
coarse granular deposits scattered along the capil-
lary loop and mesangium, provided no antibody had
been given. Therefore, we attempted to use this se-
quence to induce a glomerular disease the immuno-
fluorescent findings of which might resemble classic
circulating immune complex-induced glomerulone-
phritis [1].
Two of three rats so treated had diffuse 2 to 3 +
irregular deposits of rabbit IgG, 0 to 1 + C3 depos-
its, and 1 to 2 + coarse irregular large granular Con
A deposits in their treated kidneys. The third animal
had only Con A deposits in its treated kidney. None
of the three had deposits in the untreated kidney,
histologic abnormalities in either kidney, or protein-
uria.
Group 4: Nephritogenic effect of Con A perfusion
in rats producing endogenous anti-Con A antibody.
To ascertain whether endogenous anti-Con A anti-
bodies reacting with glomerular-bound Con A
would produce disease, Con A was perfused into
the left kidneys of four Lewis rats that were making
a high titer of anti-Con A antibodies. At sacrifice 5
days later, their left kidneys had 1 to 2+ rat IgG, 1
to 3+ C3, and 1 to 3+ Con A deposits. In general,
the deposits appeared more granular than in the rats
given Con A and heterologous anti-Con A anti-
serum (Fig. 1, B and F). Right kidneys had no IgG,
C3, or Con A deposits. All four rats had severe gb-
merulonephritis with glomerular hypercellularity
and tubulointerstitial changes confined to their left
kidneys. In contrast to the animals injected with
heterologous antibodies, these rats still had marked
glomerular PMN infiltration at sacrifice on day 5
(Fig. 2D). One of the four was proteinuric. Their
right kidneys, livers, spleens, lungs, and hearts
were histologically normal or did not differ from
controls.
Controls: Group 5: Con A perfusion followed by
systemic NRS. Subgroups of animals were sacri-
ficed at 1 and 5 days. Immunofluorescence of both
kidneys revealed only focal 0 to 2+ coarse granular
deposits of Con A, without C3 or rabbit IgG, in the
left kidney. None of the rats was histologically ab-
normal, proteinuric, or azotemic.
Group 6: Sterile saline perfusion followed by sys-
temic anti-Con A antiserum. As mentioned pre-
viously, there was no specific binding of 1251-anti-
Con A antibody in the kidneys of any of these rats.
Immunofluorescence of both kidneys was negative.
Histology was normal and none of the rats manifest-
ed proteinuria or azotemia.
Group 7: Con A perfusion followed by delayed
injection of NRS. Immunofluorescence revealed
only 0 to 2+ coarse granular deposits of Con A in
the left kidneys of three of four rats, and no deposits
in the right kidneys. There were no histologic ab-
normalities.
Group 8: Con A perfusion in sham immunized
rats. Immunofluorescence of both kidneys disclosed
no significant deposits except for 0 to 3+ coarse
granular deposits of Con A in the left kidneys. There
were no histologic abnormalities, and no rat was
proteinuric or azotemic.
Discussion
Currently accepted concepts of immunologically-
mediated glomerubonephritis postulate that non-
glomerular antigens participate in the production of
glomerular injury by combining with antibody to
form circulating immune complexes, which sub-
sequently deposit in the glomerulus. The deposition
of these complexes initiates a phbogogenic sequence
of events that culminates in histologic and function-
al damage [1]. The nature of the antigen seems to be
important only insofar as its ability to interact with
the immune and reticuboendothelial systems. Re-
cently, there has been interest in the concept that
gbomerulonephritis might also be induced by the in
situ formation of immune complexes in the glomer-
ulus, with the subsequent initiation of inflammatory
processes culminating in glomerular lesions. If this
mechanism were to involve a nonglomerular anti-
gen, by virtue of its inherent properties, this antigen
must interact with the gbomerulus, retain its anti-
genicity, and remain bound until it reacts with anti-
body.
In this study, the glycoprotein-binding properties
of the lectin Con A were utilized to "plant" an anti-
gen in the gbomeruli of rats. Perfusing Con A direct-
ly into a rat's left kidney resulted in its binding dif-
fusely along the glomerular capillary wall. Its major
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site of binding had previously been reported to be in
the glomerular basement membrane [6]. No signifi-
cant amounts of Con A were detected in other or-
gans, including the right kidney. No functional or
histologic effects resulted when 75 tg of this mito-
genic protein alone fixed diffusely in glomeruli.
When anti-Con A antibody reacted with this
amount of glomerular-bound Con A, however, gb-
merulonephritis developed. The severity, depend-
ing on the dose of antibody injected, ranged from a
mild proliferative form to a severe exudative, prolif-
erative, crescentic form. It is highly unlikely that
the glomerulonephritis was caused by the formation
and deposition of circulating immune complexes,
since the nonperfused right kidney showed no sig-
nificant immunof'luorescent or histologic abnormal-
ities. Immunofluorescence disclosed the diffuse
deposition of antibody and complement in the af-
fected kidneys. The immunofluorescent staining
patterns, however, were difficult to evaluate (see
Results) because they differed from those charac-
teristic of either circulating immune complex or
antibasement membrane antibody-induced forms of
glomerulonephritis.
The pathogenicity of immune complexes assem-
bled in situ is established in the vasculitis seen in
the Arthus reaction [141. Tissue damage from im-
mune complexes formed in situ has also been sug-
gested in several experimental disease models: thy-
roiditis produced by immunizing mice with heterol-
ogous thyroglobulin [15], orchitis following
vasectomy in rabbits [161, and tubulointerstitial
nephritis produced by immunizing rabbits with re-
nal cortical homogenates [17].
The induction of glomerular lesions by the in situ
formation of immune complexes was first suggested
in the l940s, when Kay described the delayed or
autologous phase of nephrotoxic nephritis induced
by heterologous antibasement membrane anti-
bodies [18]. The elucidation of the biphasic nature
of nephrotoxic nephritis disclosed that the autolo-
gous phase was a reaction between host antibody
and an antigen (the heterologous antibasement
membrane antibody) that had been previously
"planted" on the glomerular basement membrane.
This in situ immune complex formation was shown
to be capable of perpetuating chronic glomerular
disease, or even, if a low dose of passive antibody
was given, initiating glomerular injury [19].
Recently, Mauer et al have reported a model of
glomerulonephritis that uses the physiologic uptake
of aggregated serum proteins by the glomerular
mesangium as a means of infiltrating antigen into
the glomerulus [20]. Subsequent administration of
antibody reactive with the aggregated protein into a
rabbit given a renal transplant containing the aggre-
gate led to nephritis characterized by mesangial cell
proliferation.
Izui, Lambert, and Miescher [21] and Izui et al
[22] suggested that the spontaneously occurring gb-
merulonephritis of NZB x NZW mice arose in part
from the in situ formation of DNA-anti-DNA im-
mune complexes [21, 22]. They demonstrated in vi-
tro that DNA had a specific affinity for isolated gb-
merubar basement membrane. Furthermore, mice
that they injected with bacterial lipopolysaccharide
sequentially developed circulating DNA, anti-DNA
antibodies, circulating immune complexes, hypo-
complementemia, and glomerubar IgG, 1gM and C3
deposits. No circulating DNA-anti-DNA com-
plexes, however, were detected. Since 40% of the
elutable immunoglobulin from the kidneys had anti-
DNA activity, they postulated that the DNA-anti-
DNA complexes had formed in situ in these kid-
neys.
Our use of a lectin as an antigen in producing gb-
merulonephritis by the in situ formation of glomeru-
lar immune complexes has potential biologic signifi-
cance for several reasons. Antigens involved in hu-
man immune complex glomerubonephritis can be
either of endogenous or exogenous origin; the latter
are most often classed as products or components
of infectious agents. The widespread distribution of
lectins throughout nature, however, makes them
potential candidates as antigens that incite human
glomerulonephritis. Lectins have been found as en-
dogenous components of mammalian tissues [23],
as well as of pathogenic bacteria [24]. The surface
proteins of some viruses may also have bectin-like
properties, since they adsorb to cells via a cell sur-
face sialic acid-containing receptor protein, and this
adsorption can be prevented by removal of the cell
surface sialic acid with neuraminidase [25]. The
streptococcal antigen deposition that has been ob-
served in glomeruli early in the course of post-
streptococcal gbomerubonephritis may even repre-
sent some type of lectin-like binding [26, 27].
One can thus postulate a sequence of events in
which, during the course of an infection or inflam-
mation, proteins with lectin-like properties are re-
leased and gain access to the circulation. They may
then bind to the sugar residues of the glomerular
basement membrane, whose ready accessibility to
circulating proteins is a factor of its fenestrated
endothelial lining. Finally, when the host mounts an
antibody response, immune complexes could form
in situ, which in the proper circumstances and con-
centration might result in gbomerubonephritis.
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